POZ for effect - POZ-ZF transcription factors in cancer and development

Trends in Cell Biology

Volumn 16, Issue 11, 2006, Pages 578-587

  Kelly, Kevin F ^a   Daniel, Juliet M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRIC A BRACK PROTEIN; BROAD COMPLEX PROTEIN; FANCONI ANEMIA ZINC FINGER PROTEIN; HYPERMETHYLATED IN CANCER 1 PROTEIN; KAISO PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BCL 6; PROTEIN P53; PROTEIN ZBTB7; TRAMTRACK PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE DEVELOPMENT; CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL FATE; DEVELOPMENT; DEVELOPMENTAL DISORDER; DNA DAMAGE; FANCONI ANEMIA; GASTRULATION; GERMINAL CENTER; HEMATOPOIETIC STEM CELL; HUMAN; LIMB DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTO ONCOGENE; REGULATOR GENE; REVIEW; XENOPUS;

ANIMALS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH AND DEVELOPMENT; HUMANS; NEOPLASMS; TRANSCRIPTION FACTORS; ZINC FINGERS;

POXVIRIDAE; VERTEBRATA;

EID: 33750333540     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2006.09.003     Document Type: Review

References (94)

1. Albagli O., et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 6 (1995) 1193-1198
2. van Roy F.M., and McCrea P.D. A role for Kaiso-p120ctn complexes in cancer?. Nat. Rev. Cancer 5 (2005) 956-964
3. Stogios P.J., et al. Sequence and structural analysis of BTB domain proteins. Genome Biol. 6 (2005) R82
4. Restifo L.L., and White K. Mutations in a steroid hormone-regulated gene disrupt the metamorphosis of the central nervous system in Drosophila. Dev. Biol. 148 (1991) 174-194
5. Karim F.D., et al. The Drosophila broad-complex plays a key role in controlling ecdysone-regulated gene expression at the onset of metamorphosis. Development 118 (1993) 977-988
6. Xiong W.C., and Montell C. Tramtrack is a transcriptional repressor required for cell fate determination in the Drosophila eye. Genes Dev. 7 (1993) 1085-1096
7. Sahut-Barnola I., et al. Drosophila ovary morphogenesis: analysis of terminal filament formation and identification of a gene required for this process. Dev. Biol. 170 (1995) 127-135
8. Godt D., et al. Pattern formation in the limbs of Drosophila: bric a brac is expressed in both a gradient and a wave-like pattern and is required for specification and proper segmentation of the tarsus. Development 119 (1993) 799-812
9. Chen Z., et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12 (1993) 1161-1167
10. Nagy L., et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89 (1997) 373-380
11. Lin R.J., et al. Role of the histone deactylase complex in acute promyelocytic leukemia. Nature 391 (1998) 811-814
12. Grignani F., et al. Fusion proteins of the retinoic acid receptor-α recruit histone deactylase in promyelocytic leukemia. Nature 391 (1998) 815-818
13. Alcalay M., et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest 112 (2003) 1751-1761
14. Park D.J., et al. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Blood 102 (2003) 3727-3736
15. Muller C., et al. The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Blood 96 (2000) 3894-3899
16. Kwok C., et al. Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. Cancer Cell 9 (2006) 95-108
17. McConnell M.J., et al. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell. Biol. 23 (2003) 9375-9388
18. Insinga A., et al. Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J. 23 (2004) 1144-1154
19. Barna M., et al. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25 (2000) 166-172
20. Barna M., et al. Plzf mediates transcriptional repression of HoxD gene expression through chromatin remodeling. Dev. Cell 3 (2002) 499-510
21. Barna M., et al. Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development. Nature 436 (2005) 277-281
22. Costoya J.A., et al. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet. 36 (2004) 653-659
23. Pasqualucci L., et al. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk Lymphoma 44 Suppl. 3 (2003) S5-S12
24. Chang C.C., et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. U S A 93 (1996) 6947-6952
25. Cattoretti G., et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7 (2005) 445-455
26. Baron B.W., et al. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc. Natl. Acad. Sci. U S A 101 (2004) 14198-14203
27. Phan R.T., and Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432 (2004) 635-639
28. Polo J.M., et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat. Med. 10 (2004) 1329-1335
29. Chattopadhyay A., et al. A peptide aptamer to antagonize BCL-6 function. Oncogene 25 (2006) 2223-2233
30. Ahmad K.F., et al. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12 (2003) 1551-1564
31. Niu H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 20 (2002) 155-166
32. Calame K.L., et al. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21 (2003) 205-230
33. Shaffer A.L., et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13 (2000) 199-212
34. Turner Jr. C.A., et al. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77 (1994) 297-306
35. Reljic R., et al. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192 (2000) 1841-1848
36. Bereshchenko O.R., et al. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32 (2002) 606-613
37. Niu H., et al. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12 (1998) 1953-1961
38. Scheeren F.A., et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol. 6 (2005) 303-313
39. Fujita N., et al. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119 (2004) 75-86
40. Kojima S., et al. Testicular germ cell apoptosis in Bcl6-deficient mice. Development 128 (2001) 57-65
41. Baron B.W., et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc. Natl. Acad. Sci. U S A 99 (2002) 2860-2865
42. Wales M.M., et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1 (1995) 570-577
43. Fujii H., et al. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 16 (1998) 2159-2164
44. Chen W.Y., et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 33 (2003) 197-202
45. Chen W., et al. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6 (2004) 387-398
46. Chen W.Y., et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123 (2005) 437-448
47. Hirotsune S., et al. Genomic organization of the murine Miller-Dieker/lissencephaly region: conservation of linkage with the human region. Genome Res. 7 (1997) 625-634
48. Carter M.G., et al. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9 (2000) 413-419
49. Daniel J.M., and Reynolds A.B. The catenin p120ctn interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell. Biol. 19 (1999) 3614-3623
50. Reynolds A.B., and Carnahan R.H. Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer. Semin. Cell Dev. Biol. 15 (2004) 657-663
51. Spring C.M., et al. The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp. Cell Res. 305 (2005) 253-265
52. Park J.I., et al. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev. Cell 8 (2005) 843-854
53. Shiomi T., and Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 22 (2003) 145-152
54. Nusse R. Wnt signaling in disease and in development. Cell Res. 15 (2005) 28-32
55. Prokhortchouk A., et al. Kaiso-deficient mice show resistance to intestinal cancer. Mol. Cell. Biol. 26 (2006) 199-208
56. Filion G.J., et al. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol. Cell. Biol. 26 (2006) 169-181
57. Soubry A., et al. Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment. Cancer Res. 65 (2005) 2224-2233
58. Kelly K.F., et al. Nuclear import of the BTB/POZ transcriptional regulator Kaiso. J. Cell Sci. 117 (2004) 6143-6152
59. Kim S.W., et al. Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat. Cell Biol. 6 (2004) 1212-1220
60. Ruzov A., et al. Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development 131 (2004) 6185-6194
61. Maeda T., et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433 (2005) 278-285
62. Hoatlin M.E., et al. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 94 (1999) 3737-3747
63. Niedernhofer L.J., et al. Fanconi anemia (cross)linked to DNA repair. Cell 123 (2005) 1191-1198
64. Dai M.S., et al. The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. J. Biol. Chem. 277 (2002) 26327-26334
65. Piazza F., et al. Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis. Mol. Cell. Biol. 24 (2004) 10456-10469
66. Dhordain P., et al. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene 19 (2000) 6240-6250
67. Melnick A., et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22 (2002) 1804-1818
68. Deltour S., et al. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and γFBP-B. Proc. Natl. Acad. Sci. U S A 96 (1999) 14832-14836
69. Bajalica-Lagercrantz S., et al. Expression of the BCL6 gene in the pre- and postnatal mouse. Biochem. Biophys. Res. Commun. 247 (1998) 357-360
70. Mackler S.A., et al. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J. Neurosci. 20 (2000) 6210-6217
71. Korutla L., et al. NAC1, a POZ/BTB protein present in the adult mammalian brain, triggers apoptosis after adenovirus-mediated overexpression in PC-12 cells. Neurosci. Res. 46 (2003) 33-39
72. Defossez P.A., et al. The human enhancer blocker CTC-binding factor interacts with the transcription factor Kaiso. J. Biol. Chem. 280 (2005) 43017-43023
73. Valenta T., et al. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies. EMBO J. 25 (2006) 2326-2337
74. Sengupta N., and Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 93 (2004) 57-67
75. David G., et al. Histone deactylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16 (1998) 2549-2556
76. Chauchereau A., et al. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene 23 (2004) 8777-8784
77. Dhordain P., et al. The LAZ3(Bcl-6) oncoprotein recruits a SMRT/mSin3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26 (1998) 4645-4651
78. Huynh K.D., and Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17 (1998) 2473-2484
79. Huynh K.D., et al. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14 (2000) 1810-1823
80. Lemercier C., et al. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 277 (2002) 22045-22052
81. Chevallier N., et al. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood 103 (2004) 1454-1463
82. Daniel J.M., et al. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 13 (2002) 2911-2919
83. Prokhortchouk A., et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15 (2001) 1613-1618
84. Yoon H.G., et al. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12 (2003) 723-734
85. Kelly K.F., et al. NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J. Cell. Sci. 117 (2004) 2675-2686
86. Pinte S., et al. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J. Biol. Chem. 279 (2004) 38313-38324
87. Deltour S., et al. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 22 (2002) 4890-4901
88. Staller P., et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell. Biol. 3 (2001) 392-399
89. Adhikary S., et al. Miz1 is required for early embryonic development during gastrulation. Mol. Cell. Biol. 23 (2003) 7648-7657
90. Pendergrast P.S., et al. FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol. Biol. Cell 13 (2002) 915-929
91. Rodova M., et al. Regulation of the rapsyn promoter by Kaiso and delta-catenin. Mol. Cell. Biol. 24 (2004) 7188-7196
92. Takamori M., et al. BAZF is required for activation of naive CD4 T cells by TCR triggering. Int. Immunol. 16 (2004) 1439-1449
93. Reuter S., et al. APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J. 17 (1998) 215-222
94. Kiefer H., et al. ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons. Mol. Cell. Biol. 25 (2005) 1713-1729